Non-Steroidal Anti-Inflammatory (NSAID)

Diclofenac Sodium

Precision-dosed sterile injectable for acute and chronic pain management — manufactured under GMP conditions at Sandri, Rajasthan.

VialPFS 25 mg/mL · 75 mg/3 mL GMP Certified Made in India
Pharmacology

Mechanism of Action

Diclofenac inhibits COX-1 and COX-2 enzymes, reducing prostaglandin synthesis. This dual inhibition delivers potent analgesic, anti-inflammatory, and antipyretic effects — making it one of the most prescribed injectable NSAIDs globally.

Clinical Evidence

Key Clinical Data Points

60–80%
Pain reduction within 30 min
vs placebo in post-op studies
2–6 hrs
Duration of analgesic effect
single 75 mg IM dose
99%
Plasma protein binding
highly albumin-bound
1–2 hr
Peak plasma concentration
after IM administration
Therapeutic Applications

Approved Indications

Post-operative pain management
Acute musculoskeletal disorders
Renal colic & biliary colic
Cancer pain (adjunct therapy)
Migraine & acute pain episodes
Manufacturing Advantage

Why Manufacture Diclofenac with Addams

High-purity API sourcing with full CoA documentation
pH-controlled buffer system for enhanced stability
Nitrogen-purged vials to prevent oxidation
Each batch validated against BP/USP monograph
Request Manufacturing Quote
Get pricing, MOQ, and feasibility for Diclofenac Sodium within 24 hours.
Get Quote → Start Discussion
Ready to Manufacture Diclofenac?
Our team responds within 24 hours with a full feasibility and pricing overview.
Get QuoteSee Full Portfolio